OptoTree
OptoTree helps doctors detect and monitor diabetic retinopathy earlier using its Vasculomics platform. The technology analyzes 3D micro-vascular geometry to stage disease and assess treatment response, leveraging OCT-A imaging and AI-assisted analysis. Vasculomics is a proprietary biomarker platform backed by patents and applied to retinal imaging and oncology drug discovery. The solution is delivered as a cloud-based service to ophthalmologists, clinics, and hospitals, with data informatics offerings for pharmaceutical and healthcare organizations. It is a collaboration with Joslin Diabetes Center, positioning OptoTree in the medical imaging and biomarker space for diabetic retinopathy.
OptoTree
OptoTree helps doctors detect and monitor diabetic retinopathy earlier using its Vasculomics platform. The technology analyzes 3D micro-vascular geometry to stage disease and assess treatment response, leveraging OCT-A imaging and AI-assisted analysis. Vasculomics is a proprietary biomarker platform backed by patents and applied to retinal imaging and oncology drug discovery. The solution is delivered as a cloud-based service to ophthalmologists, clinics, and hospitals, with data informatics offerings for pharmaceutical and healthcare organizations. It is a collaboration with Joslin Diabetes Center, positioning OptoTree in the medical imaging and biomarker space for diabetic retinopathy.